{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:05:12Z","timestamp":1793153112947,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8,13]]},"DOI":"10.7759\/cureus.9728","type":"journal-article","created":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T07:30:17Z","timestamp":1597390217000},"source":"Crossref","is-referenced-by-count":8,"title":["Neutrophils to Lymphocyte Ratio as a Biomarker in Bronchiectasis Exacerbation: A Retrospective Study"],"prefix":"10.7759","author":[{"given":"Vasiliki E","family":"Georgakopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Trakas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Damaskos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Garmpis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgenia","family":"Karakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rea","family":"Chatzikyriakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiota","family":"Lambrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xanthi","family":"Tsiafaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4104\/pcrj.2011.00007","article-title":"Primary care summary of the British Thoracic Society Guideline on the management of non-cystic fibrosis bronchiectasis","volume":"20","author":"Hill A","year":"2011","unstructured":"Hill A, Pasteur M, Cornford C, Sally, W, Bilton D. Primary care summary of the British Thoracic Society Guideline on the management of non-cystic fibrosis bronchiectasis. Prim Care Respir J. 2011, 20:135-140. 10.4104\/pcrj.2011.00007","journal-title":"Prim Care Respir J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201507-472OC","article-title":"Etiology of non-cystic fibrosis bronchiectasis in adults and its correlation to disease severity","volume":"12","author":"Lonni S","year":"2015","unstructured":"Lonni S, Chalmers JD, Goeminne PC, et al.. Etiology of non-cystic fibrosis bronchiectasis in adults and its correlation to disease severity. Ann Am Thorac Soc. 2015, 12:1764-1770. 10.1513\/AnnalsATS.201507-472OC","journal-title":"Ann Am Thorac Soc"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00051-2017","article-title":"Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research","volume":"49","author":"Hill AT","year":"2017","unstructured":"Hill AT, Haworth CS, Aliberti S, et al.. Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research. Eur Respir J. 2017, 49:1700051. 10.1183\/13993003.00051-2017","journal-title":"Eur Respir J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.arbres.2017.07.016","article-title":"Normativa sobre el tratamiento de las bronquiectasias en el adulto: Spanish guidelines on treatment of bronchiectasis in adults","volume":"54","author":"Mart\u00ednez-Garc\u00eda M\u00c1","year":"2018","unstructured":"Mart\u00ednez-Garc\u00eda M\u00c1, M\u00e1iz L, Olveira C, et al.. Normativa sobre el tratamiento de las bronquiectasias en el adulto: Spanish guidelines on treatment of bronchiectasis in adults. Arch Bronconeumol. 2018, 54:88-98. 10.1016\/j.arbres.2017.07.016","journal-title":"Arch Bronconeumol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0055-2019","article-title":"The biology of pulmonary exacerbations in bronchiectasis","volume":"28","author":"Amati F","year":"2019","unstructured":"Amati F, Simonetta E, Gramegna A, Paolo T, Contarini M, Blasi F, Aliberti S. The biology of pulmonary exacerbations in bronchiectasis. Eur Respir Rev. 2019, 28:190055. 10.1183\/16000617.0055-2019","journal-title":"Eur Respir Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2016.06.007","article-title":"Challenges in managing Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis","volume":"117","author":"Wilson R","year":"2016","unstructured":"Wilson R, Aksamit T, Aliberti S, et al.. Challenges in managing Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis. Respir Med. 2016, 117:179-189. 10.1016\/j.rmed.2016.06.007","journal-title":"Respir Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/thx.53.8.685","article-title":"Increases in CD4+ T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis","volume":"53","author":"Gaga M","year":"1998","unstructured":"Gaga M, Bentley AM,  Humbert M, et al.. Increases in CD4+ T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis. Thorax. 1998, 53:685-691. 10.1136\/thx.53.8.685","journal-title":"Thorax"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2147\/copd.s6133","article-title":"The pathophysiology of bronchiectasis","volume":"4","author":"King PT","year":"2009","unstructured":"King PT. The pathophysiology of bronchiectasis. Int J Chron Obstruct Pulmon Dis. 2009, 4:411-419. 10.2147\/copd.s6133","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201203-0487OC","article-title":"Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis","volume":"186","author":"Chalmers JD","year":"2012","unstructured":"Chalmers JD, Smith MP, McHugh BJ, Doherty C, Govan JR, Hill AT. Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med. 2012, 186:657-665. 10.1164\/rccm.201203-0487OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2014.03.003","article-title":"Neutrophil to lymphocyte ratio in relation to risk of all-cause mortality and cardiovascular events among patients undergoing angiography or cardiac revascularization: a meta-analysis of observational studies","volume":"1","author":"Wang X","year":"2014","unstructured":"Wang X, Zhang G, Jiang X, Zhu H, Lu Z, Xu L. Neutrophil to lymphocyte ratio in relation to risk of all-cause mortality and cardiovascular events among patients undergoing angiography or cardiac revascularization: a meta-analysis of observational studies. Atherosclerosis. 2014, 1:206-213. 10.1016\/j.atherosclerosis.2014.03.003","journal-title":"Atherosclerosis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju124","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis","volume":"106","author":"Templeton AJ","year":"2014","unstructured":"Templeton AJ, McNamara MG, \u0160eruga B, et al.. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014, 106:dju124. 10.1093\/jnci\/dju124","journal-title":"J Natl Cancer Inst"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.14894","article-title":"Neutrophil-to-lymphocyte ratio: an emerging marker predicting prognosis in elderly adults with community-acquired pneumonia","volume":"65","author":"Cataudella E","year":"2017","unstructured":"Cataudella E, Giraffa CM, Di Marca S, et al.. Neutrophil-to-lymphocyte ratio: an emerging marker predicting prognosis in elderly adults with community-acquired pneumonia. J Am Geriatr Soc. 2017, 65:1796-1801. 10.1111\/jgs.14894","journal-title":"J Am Geriatr Soc"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S147261","article-title":"Eosinophilic and non-eosinophilic COPD patients with chronic respiratory failure: neutrophil-to-lymphocyte ratio as an exacerbation marker","volume":"12","author":"Acart\u00fcrk Tun\u00e7ay E","year":"2017","unstructured":"Acart\u00fcrk Tun\u00e7ay E, Karakurt Z, Aksoy E, et al.. Eosinophilic and non-eosinophilic COPD patients with chronic respiratory failure: neutrophil-to-lymphocyte ratio as an exacerbation marker. Int J Chron Obstruct Pulmon Dis. 2017, 12:3361-3370. 10.2147\/COPD.S147261","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S188578","article-title":"Total lymphocyte count, neutrophil-lymphocyte ratio, and platelet-lymphocyte ratio as prognostic factors in advanced non-small cell lung cancer with chemoradiotherapy","volume":"10","author":"Song X","year":"2018","unstructured":"Song X, Chen D, Yuan M, Wang H, Wang Z. Total lymphocyte count, neutrophil-lymphocyte ratio, and platelet-lymphocyte ratio as prognostic factors in advanced non-small cell lung cancer with chemoradiotherapy. Cancer Manag Res. 2018, 10:6677-6683. 10.2147\/CMAR.S188578","journal-title":"Cancer Manag Res"},{"key":"ref15","article-title":"The neutrophil-to-lymphocyte ratio in clinical practice","volume":"10","author":"G\u03ccra\u011fa\u03b7 A","year":"2016","unstructured":"G\u03ccra\u011fa\u03b7 A,  Demirer \u0396. The neutrophil-to-lymphocyte ratio in clinical practice. Can Urol Assoc J. 2016, 10:141-142.","journal-title":"Can Urol Assoc J"},{"key":"ref16","article-title":"Ratio of neutrophil to lymphocyte counts--rapid and simple parameter of systemic inflammation and stress in critically ill","volume":"102","author":"Zahorec R","year":"2001","unstructured":"Zahorec R. Ratio of neutrophil to lymphocyte counts--rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy. 2001, 102:5-14.","journal-title":"Bratisl Lek Listy"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.5114\/ceji.2017.72808","article-title":"Can mean platelet volume and neutrophil-to-lymphocyte ratio be biomarkers of acute exacerbation of bronchiectasis in children?","volume":"42","author":"Nacaroglu HT","year":"2017","unstructured":"Nacaroglu HT, Erdem SB, Karaman S, Yazici S, Can D. Can mean platelet volume and neutrophil-to-lymphocyte ratio be biomarkers of acute exacerbation of bronchiectasis in children?. Cent Eur J Immunol. 2017, 42:358-362. 10.5114\/ceji.2017.72808","journal-title":"Cent Eur J Immunol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/9874068","article-title":"Is there a correlation between new scoring systems and systemic inflammation in stable bronchiectasis?","volume":"2017","author":"Coban H","year":"2017","unstructured":"Coban H, Gungen AC. Is there a correlation between new scoring systems and systemic inflammation in stable bronchiectasis?. Can Respir J. 2017, 2017:9874068. 10.1155\/2017\/9874068","journal-title":"Can Respir J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201712-2423OC","article-title":"Blood neutrophils are reprogrammed in bronchiectasis","volume":"198","author":"Bedi P","year":"2018","unstructured":"Bedi P, Davidson DJ, McHugh BJ, Rossi AG, Hill AT. Blood neutrophils are reprogrammed in bronchiectasis. Am J Respir Crit Care Med. 2018, 198:880-890. 10.1164\/rccm.201712-2423OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/795140","article-title":"The role of the high-sensitivity C-reactive protein in patients with stable non-cystic fibrosis bronchiectasis","volume":"2013","author":"Hsieh MH","year":"2013","unstructured":"Hsieh MH, Fang YF, Chen GY, et al.. The role of the high-sensitivity C-reactive protein in patients with stable non-cystic fibrosis bronchiectasis. Pulm Med. 2013, 2013:795140. 10.1155\/2013\/795140","journal-title":"Pulm Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.arbres.2019.12.017","article-title":"C-reactive protein concentration in steady-state bronchiectasis: prognostic value of future severe exacerbations. Data from the Spanish Registry of Bronchiectasis (RIBRON) (IN PRESS)","author":"Posadas T","year":"2020","unstructured":"Posadas T, Oscullo G, Zaldivar E, et al.. C-reactive protein concentration in steady-state bronchiectasis: prognostic value of future severe exacerbations. Data from the Spanish Registry of Bronchiectasis (RIBRON) (IN PRESS). Arch Bronconeumol. 2020, 10.1016\/j.arbres.2019.12.017","journal-title":"Arch Bronconeumol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201309-1575OC","article-title":"The bronchiectasis severity index. An international derivation and validation study","volume":"189","author":"Chalmers JD","year":"2014","unstructured":"Chalmers JD, Goeminne P, Aliberti S, et al.. The bronchiectasis severity index. An international derivation and validation study. Am J Respir Crit Care Med. 2014, 189:576-585. 10.1164\/rccm.201309-1575OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3109\/02770903.2014.975357","article-title":"Characteristics of eosinophilic and non-eosinophilic asthma during treatment with inhaled corticosteroids","volume":"52","author":"Furukawa T","year":"2015","unstructured":"Furukawa T, Sakagami T, Koya T, et al.. Characteristics of eosinophilic and non-eosinophilic asthma during treatment with inhaled corticosteroids. J Asthma. 2015, 52:417-422. 10.3109\/02770903.2014.975357","journal-title":"J Asthma"},{"key":"ref24","article-title":"Neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease: a retrospective study","volume":"37(2)","author":"G\u00fcnay E","year":"2014","unstructured":"G\u00fcnay E, Sar\u0131n\u00e7 Ula\u015fl\u0131 S, Akar O, Ahsen A, G\u00fcnay S, Koyuncu T, \u00dcnl\u00fc M.  Neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease: a retrospective study. Inflammation. 2014, 37(2):374-380. doi:10.1007\/s10753-013-9749-1","journal-title":"Inflammation"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/37625-neutrophils-to-lymphocyte-ratio-as-a-biomarker-in-bronchiectasis-exacerbation-a-retrospective-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T14:20:54Z","timestamp":1707488454000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/37625-neutrophils-to-lymphocyte-ratio-as-a-biomarker-in-bronchiectasis-exacerbation-a-retrospective-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,13]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.9728","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8,13]]}}}